Treatment of refractory dry eye associated with graft versus host disease with 0.03% tacrolimus eyedrops.
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Vazquez A
Grupos
Abstract
We investigate the efficacy of 0.03% topical tacrolimus eyedrops for the treatment of dry eye in graft versus host disease (GVHD) patients resistant/intolerant to 0.05% topical cyclosporine.
Datos de la publicación
- ISSN/ISSNe:
- 1080-7683, 1557-7732
- Tipo:
- Article
- Páginas:
- 776-783
- PubMed:
- 23947579
- Factor de Impacto:
- 0,804 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS Mary Ann Liebert Inc.
Citas Recibidas en Web of Science: 38
Documentos
- No hay documentos
Filiaciones
Cita
SANZ E,UDAONDO P,GARCÍA S,Vazquez A,DIAZ M. Treatment of refractory dry eye associated with graft versus host disease with 0.03% tacrolimus eyedrops. J Ocul Pharmacol Ther. 2013. 29. (8):p. 776-783. IF:1,420. (3).
Portal de investigación